Entradas

Mostrando las entradas etiquetadas como Farmacopea

British Pharmacopoeia 2011 - Introduction

Imagen
British Pharmacopoeia 2011 - Introduction The British Pharmacopoeia (BP) is the official collection of standards for UK medicinal products and pharmaceutical substances. Produced by the British Pharmacopoeia Commission Secretariat of the Medicines and Healthcare products Regulatory Agency, the BP makes a valuable contribution to public health by setting publicly available standards for the quality of medicines. Pronto Ebook disponible ...

Admissions USP33 NF28 2010

Imagen
Articles Admitted to USP 33 by Supplement: The United States Pharmacopeia–National Formulary and its Supplements become official six months after being released to the public. The USP–NF, which is released on November 1 of each year, becomes official on May 1 of the following year. This change was adopted to give users more time to bring their methods and procedures into compliance with new and revised USP–NF requirements. The table below describes the new official dates. The 2009 USP 32–NF 27, and the Supplements and Interim Revision Announcements (IRAs) to that edition, will be official until May 1, 2010, at which time the USP 33–NF 28 becomes official.

Admissions British Pharmacopoeia 2010

Imagen
Admissions BP2010: The British Pharmacopoeia 2010 supersedes the British Pharmacopoeia 2009. It has been prepared by the British Pharmacopoeia Commission, with the collaboration and support of its Expert Advisory Groups and Panels of Experts, and contains approximately 3300 monographs for substances, preparations and articles used in the practice of medicine. Some of these monographs are of national origin while others have been reproduced from the 6th edition of the European Pharmacopoeia. This edition, together with its companion edition, the British Pharmacopoeia (Veterinary) 2010, incorporates all the monographs of the 6th edition of the European Pharmacopoeia as amended by Supplements 6.1 to 6.5. The user of the British Pharmacopoeia thereby benefits by finding within this one, comprehensively indexed, compendium all current United Kingdom pharmacopoeial standards for medicines for human use. The new edition comprises five volumes as follows.